Alto Neuroscience, Inc. (ANRO)

NYSE · Pharmaceutical Preparations · Inc. DE

What they're doing

Between 2026-08-02 and 2026-10-31, public records show 2 signals for Alto Neuroscience, Inc.. Most notable: 2026-08-27: Filed 8-K disclosing director or officer change; 2026-09-29: Smith Nicholas Conrad (officer) sold $2.9M of stock. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.

Generated 2026-10-31 from public records.

Signals, last 12 months

  1. Large insider sale
    Smith Nicholas Conrad (officer) sold $2.9M of stock
  2. Material 8-K filing
    Filed 8-K disclosing director or officer change
  3. Material 8-K filing
    Filed 8-K disclosing material agreement
  4. Material 8-K filing
    Filed 8-K disclosing director or officer change
  5. Material 8-K filing
    Filed 8-K disclosing director or officer change
  6. Material 8-K filing
    Filed 8-K disclosing material agreement

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2026-10-02Smith Nicholas ConradofficerM55,0002.32$127,600
2026-09-30Smith Nicholas ConradofficerS88626.87$23,807
2026-09-30Smith Nicholas ConradofficerS23,17025.78$597,290
2026-09-30Smith Nicholas ConradofficerM24,0562.35$56,532
2026-09-29Smith Nicholas ConradofficerS110,83026.58$2,946,150
2026-09-29Smith Nicholas ConradofficerM54,3752.35$127,781
2026-09-29Smith Nicholas ConradofficerM56,4552.35$132,669
2026-05-14Etkin AmitdirectorG400,0000$0
2026-05-14Etkin AmitdirectorG400,0000$0
2026-03-01Etkin AmitdirectorF6,22719.69$122,610
2026-03-01Smith Nicholas ConradofficerF2,80619.69$55,250
2026-03-01Etkin AmitdirectorF6,22719.69$122,610
2026-03-01Smith Nicholas ConradofficerF2,80619.69$55,250
2024-07-10Savitz AdamofficerP2,93113.22$38,748
2024-07-10Savitz AdamofficerP2,93113.22$38,748
2024-07-09Savitz AdamofficerP10,68112.53$133,833
2024-07-09Savitz AdamofficerP1,38813.15$18,252
2024-07-09Savitz AdamofficerP10,68112.53$133,833
2024-07-09Savitz AdamofficerP1,38813.15$18,252
2024-03-28Smith Nicholas ConradofficerP1,60015.8$25,280
2024-03-28Smith Nicholas ConradofficerP4,55016.56$75,348
2024-03-01Smith Nicholas ConradofficerA19,1530$0
2024-03-01Etkin AmitdirectorA34,7110$0
2024-02-06Apeiron Investment Group Ltd.; Apeiron Presight Capital Fund II, L.P.; Angermayer ChristianotherC251,881——
2024-02-06Apeiron Investment Group Ltd.; Apeiron Presight Capital Fund II, L.P.; Angermayer ChristianotherC674,658——
2024-02-06Alpha Wave Global, LP; Alpha Wave Ventures GP, Ltd; Lunate Holding RSC Ltd; Chimera Investment LLCten percent ownerC1,962,995——
2024-02-06Alpha Wave Global, LP; Alpha Wave Ventures GP, Ltd; Lunate Holding RSC Ltd; Chimera Investment LLCten percent ownerC1,144,762——
2024-02-06Alpha Wave Global, LP; Alpha Wave Ventures GP, Ltd; Lunate Holding RSC Ltd; Chimera Investment LLCten percent ownerP600,00016$9,600,000
2024-02-06York GwilldirectorC23,917——
2024-02-06Smith Nicholas ConradofficerP1,56316$25,008
2024-02-06Cox Christopher NixondirectorC588,898——
2024-02-06Cox Christopher NixondirectorC126,755——
2024-02-06Savitz AdamofficerC7,851——
2024-02-06Savitz AdamofficerP17,00016$272,000
2024-02-06Etkin AmitdirectorC11,777——
2024-02-06Etkin AmitdirectorP3,12516$50,000
2024-02-06Chen Po Yu (Jeff)directorC39,259——
2024-02-06Chen Po Yu (Jeff)directorC8,450——

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings